Fundraising FoxColorcon Ventures
Corporate VCSeed–Series B
Also known as Colorcon
Find your way into Colorcon Ventures
Sign up to see every warm intro you have to Colorcon Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Colorcon Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Colorcon Ventures backs innovative startups across the pharmaceutical and nutraceutical sectors, prioritizing technologies that improve patient compliance and authenticate dosage forms to fight counterfeiting. It targets transformational approaches that disrupt traditional dosage delivery, smart solutions for digital and personalized medicine, breakthrough manufacturing innovations, and intelligent systems addressing unmet needs in pharma technologies and supply chains. Beyond capital, the firm offers strategic support including commercial consultation and guidance on sales and scientific development. It focuses on early and mid-stage companies with product-market fit and revenue growth, and co-invests with top-tier VC firms. It explicitly does not invest in active pharmaceutical ingredients or therapeutic molecule development.
Source: firm website, verified Oct 2, 2026.
What they invest in
from 11 of 14 portfolio companiesBiotech ×7AI & Machine Learning ×4Healthtech ×4Digital Health ×3Medical Devices ×3Deep Tech ×2Wellness & Fitness ×2Advanced Manufacturing ×1
HQs:United States×10United Kingdom×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×32 founders×63 founders×1
Investments · 14 tracked
founders shown can be your intro pathBy year:2026 · 12022 · 12019 · 12016 · 14 dated
Apprentice builds AI agents and cloud manufacturing software for regulated production environments such as pharmaceutical and life sciences manufacturing.
Advanced ManufacturingAI & Machine LearningSaaSJersey City, US
Angelo Stracquatanio(Executive Officer, Director, Promoter)in
Co-investorsICONIQ GrowthAlkeon InnovationCerity Partners VenturesGFR FundHemi Ventures, LlcICONIQ+5 more
Cerity Partners provides investment management and wealth advisory services to individuals and families, offering full portfolio management, coordination with existing advisors, or advisory guidance.
Fintech
Jessica Farrell(Partner)inKurt Miscinski(CEO & President)in
Co-investorsCerity Partners VenturesGenstarLightyearW Capital PartnersWarburg PincusWest Coast Financial
A biopharmaceutical company developing a pipeline of long-acting therapeutic candidates, including GLP-1 receptor agonists, amylin DACRAs, a PYY receptor agonist, and a glucagon receptor agonist.
BiotechSaratoga, US
Mitragotri Mitragotri(Executive Officer, Director)Ravi Srinivasan(Executive Officer, Director)in
Co-investors7G BioVenturesCerity Partners VenturesHikma VenturesSanofi VenturesJDRF T1D Fund
Mend develops clinically formulated nutrition products designed to support healing and recovery, marketed as "food as medicine." It partners with physicians to offer digital health coaching, remote patient monitoring, and nutritional formulas for patients across stages of recovery.
Digital HealthHealthtechWellness & FitnessNew York, US
Eziah Syed(Executive Officer, Director)inJ Whitney Stevens(Founder)inDaniel Ripma(Executive Officer, Director)
BoardJustin Kamine(Director)Mark Kolb(Director)
Co-investorsAlumni VenturesCerity Partners VenturesiSelect Fund
Nourished makes personalised 7-layer nutrient gummy "stacks" using patented 3D-printing technology, formulating custom blends of vitamins, micronutrients, and superfoods based on a customer quiz.
ConsumerDirect to ConsumerWellness & Fitness
Melissa Snover(CEO & Founder)
Co-investorsCerity Partners VenturesCIBUS ENTERPRISE FUND II LPFuture Planet CapitalRiverPark VenturesSanno Capital GmbHADM Ventures
South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.
Daly City, US
Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)
BoardElizabeth Stanley(Director)
Co-investorsAlta PartnersCerity Partners Ventures5AM VenturesAlexandriaDCVC (Data Collective)DCVC Bio+2 more
Numerion combines drug discovery expertise with machine learning and computational chemistry.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Alex Levy(Founder)inIzhar Wallach(Founder)inSteve Worland(CEO)inPamela Tsuruda(VP, Biology)Mark Sabat(VP, Medicinal Chemistry)inKate Stafford(VP, Machine Learning)in
Co-investorsB Capital GroupB4 CapitalDCVC (Data Collective)Dolby Family VenturesNEXT CanadaY Combinator+12 more
.jpeg){kind=logo}
Phytolon produces natural food colors derived from baker's yeast fermentation technology, offering vivid hues with heat stability and clean label credentials for food manufacturers.
BiotechClimate TechFoodTechNew Materials
Halim Jubran(Co-founder & CEO)inTal Zeltzer(Co-founder & CTO)in
Co-investorsCIBUS ENTERPRISE FUND II LPTrendlines Group
Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.
BiotechDeep TechDigital HealthHealthtechBoston, US
Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)
BoardTeymour Boutros-Ghali(Director)inMartin Madaus(Director)
Co-investorsBill & Melinda Gates FoundationBold Capital PartnersCerity Partners VenturesPortal InnovationsSafar PartnersSky9 Capital
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in
BoardVasudev Bailey(Director)in
Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcBlue Bear VenturesDroia Ventures+8 more
.png)
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)
BoardJohn LaMattina(Director)in
Co-investorsAMR Action FundK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP ParibasBNP Paribas Asset Management Europe+2 more
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.
AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US
Jo Varshney(Founder & Chief Executive Officer)inDr. Vivek Gupta, Ph.D.(Scientific Co-Founder)
Co-investorsAmplify PartnersCerity Partners VenturesDeepwater Asset ManagementIntel CapitalLoup VenturesNextwave [X] Partners+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Remedy HealthThornhill
Portfolio news
latest coverage across their companiesVedanta Biosciences · finsmes.com · Aug 6, 2026
Phytolon · finsmes.com · May 26, 2026
Unnatural Products · finance.yahoo.com · Mar 16, 2026
Syntis Bio · finsmes.com · Jul 1, 2025
Frequently asked questions
- How many investments has Colorcon Ventures made?
- Colorcon Ventures has 14 tracked investments, including 1 dated in the last 24 months.
- What stage does Colorcon Ventures invest at?
- Colorcon Ventures invests at the Seed, Series A, Series B stages.
- What is Colorcon Ventures's typical check size?
- Colorcon Ventures typically writes checks of $500K – $2.5M.
- What sectors does Colorcon Ventures focus on?
- Colorcon Ventures focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Digital Health, FoodTech, Healthtech, Medical Devices, Wellness & Fitness.
- Who does Colorcon Ventures co-invest with?
- Colorcon Ventures most often shares deals with Cerity Partners Ventures, CIBUS ENTERPRISE FUND II LP, B Capital Group, among 63 tracked co-investors.
Similar investors
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
P5 Health Ventures (P5HV) is an investment firm with a primary focus on healthcare technologies, backing companies that use AI and technology to lower the cost of care while improving quality and accessibility.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Cerity Partners Ventures provides Venture Capital as a Service (VCaaS) for corporations, helping them launch and manage venture capital programs and invest in startups. It has partnered with over 25 corporations and its portfolio includes more than 100 companies.